Results 1 to 8 of 8
Page 1 of 1
TypeTitleAuthor(s)YearViews
Antitumor agents 294. Novel E-ring-modified camptothecin-4β-anilino- 4′-O-demethyl-epipodophyllotoxin conjugates as DNA topoisomerase i inhibitors and cytotoxic agentsYe, D; Shi, Q; Leung, CH; Kim, SW; Park, SY; Gullen, EA; Jiang, ZL; Zhu, H; MorrisNatschke, SL; Cheng, YC; Lee, KH201292
 
Research findings from nonpharmaceutical intervention studies for pandemic influenza and current gaps in the researchAiello, AE; Coulborn, RM; Aragon, TJ; Baker, MG; Burrus, BB; Cowling, BJ; Duncan, A; Enanoria, W; Fabian, MP; Ferng, Yh; Larson, EL; Leung, GM; Markel, H; Milton, DK; Monto, AS; Morse, SS; Navarro, JA; Park, SY; Priest, P; Stebbins, S; Stern, AM; Uddin, M; Wetterhall, SF; Vukotich Jr, CJ201097
 
Dynamic torsional resistance of nickel-titanium rotary instrumentsPark, SY; Cheung, GSP; Yum, J; Hur, B; Park, JK; Kim, HC2010172
 
Asian society of gynecologic oncology workshop 2010Suh, DH; Kim, JW; Aziz, MF; Devi, UK; Ngan, HYS; Nam, JH; Kim, SC; Kato, T; Ryu, HS; Fujii, S; Lee, YS; Kim, JH; Kim, TJ; Kim, YT; Wang, KL; Lee, TS; Ushijima, K; Shin, SG; Chia, YN; Wilailak, S; Park, SY; Katabuchi, H; Kamura, T; Kang, SB2010297
 
Findings, gaps, and future direction for research in nonpharmaceutical interventions for pandemic influenza.Vukotich Jr, CJ; Coulborn, RM; Aragon, TJ; Baker, MG; Burrus, BB; Aiello, AE; Cowling, BJ; Duncan, A; Enanoria, W; Fabian, MP; Ferng, YH; Larson, EL; Leung, GM; Markel, H; Milton, DK; Monto, AS; Morse, SS; Navarro, JA; Park, SY; Priest, P; Stebbins, S; Stern, AM; Uddin, M; Wetterhall, SF201075
 
ATP modulates poly(ADP-ribose) polymerase-1-facilitated topoisomerase I-linked DNA religation in the presence of camptothecinPark, SY; Leung, CH; Cheng, YC2008160
 
Apurinic/apyrimidinic endonuclease-1 protein level is associated with the cytotoxicity of L-configuration deoxycytidine analogs (troxacitabine and β-L-2′,3′-dideoxy-2′,3′-didehydro-5-fluorocytidine) but not D-configuration deoxycytidine analogs (gemcitabine and β-D-arabinofuranosylcytosine)Lam, W; Park, SY; Leung, CH; Cheng, YC200655
 
Phase 3, randomized, double-blind, dummy-controlled, trial of radiofrequency ablation (RFA) + lyso-thermosensitive liposomal doxorubicin (LTLD, Thermodox), for hepatocellular carcinoma (HCC) lesions 3-7 cmTak, WY; Lin, SM; Wang, Y; Zheng, J; Izzo, F; Park, SY; Chen, MH; Wong, SN; Xu, R; Peng, CY; Chiou, YY; Huang, GT; Lee, JY; Sherman, M; Abdullah, BJJ; Lee, JS; Wang, JH; Borys, N; Poon, RTP; Lencioni, R-32
 
Page 1 of 1
Export Records
Step 1: Select content and export format
  • Citation only
Step 2: Select export method
  • Download